Seonglae ChoObesity Drugs
Obesity Companies
Industrial analysis
Pricing In The End of Obesity
The world is about to radically change and Wall Street is frantically trying to figure out who the winners and losers will be.
https://investmenttakes.substack.com/p/pricing-in-the-end-of-obesity
비만은 당신의 책임이 아닙니다
[미라클레터] 미라클모닝을 하는 이들의 참고서
https://stibee.com/api/v1.0/emails/share/QzsxwJ0Q2Xn8xDVQWzeeyu83XI28lgQ
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014
FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014
‘Skinny jabs’: weight-loss drugs set for new boom as generic versions emerge
Alternatives to costly Wegovy and Saxenda will make such treatments more widely available worldwide
https://www.theguardian.com/business/article/2024/jun/25/skinny-jabs-weight-loss-drugs-generic-ozempic-wegovy-saxenda
